Growing access to postexposure prophylaxis (PEP) in Vietnam has seen rabies cases decline 82% from 1994-2016—but some pregnant and breastfeeding women still avoid it, with deadly consequences.

Two new studies bring critical insight to curbing cholera in sub-Saharan Africa.

In 2016, India claimed to launch national cancer screening campaigns. A year later, the country has yet to provide preventive care for women and girls.70,000 Indian women die of cervical cancer every year, accounting for 27% of cervical cancer deaths worldwide. A scarcity…

Researchers are using the principles of biological vaccines to administer small doses of fake news in the hope of building immunity against the tactics of bogus content-makers.The online game—now available to play—uses the psychological theory of inoculation to build up…

Jaime Sepulveda lives global health. A veteran of senior health posts in Mexico’s government and a leadership position at the Gates Foundation, Sepulveda designed Mexico’s universal vaccination program and founded the country’s National AIDS Council. (An HIV/AIDS clinic in…

A YouTube video challenging the benefits of the human papillomavirus (HPV) vaccine, by filmmaker Joan Shenton, demonstrates why film has become a choice tool for vaccine critics.

The 2014 Ebola outbreak exposed some harsh realities—not least that clinical research into Ebola therapeutics and vaccines hadn’t advanced far enough to stop the devastation in West Africa.

The search for a vaccine against disabling chikungunya virus, endemic among 1.3 billion people living in the tropics and sub-tropics, is moving full speed ahead.   With promising options in the pipeline—including a modified measles vaccine—epidemiologists, vaccine…

Deaths from wildly infectious measles are lower than ever, dropping south of 100,000 for the first time in 2016, according to the WHO.With the help of Gavi and 5.5 billion measles vaccine doses doled out since 2000, deaths plummeted 84% from 2000-2016, from 550,100 to 89,…

Yesterday’s announcement that WHO has prequalified the first conjugate vaccine for typhoid offers a major boost to prevention efforts against a disease that causes 11–20 million cases annually and up to 161,000 deaths. The vaccine—Bharat Biotech’s Typbar-TCV®—offers…